Company intelligence / Profile preview

Typharm

Norwich/Rackheath, England, United Kingdomtypharm.com ↗
Ownership
Private
Employees
~8
Development stage
Other
01

Overview

Typharm develops and markets specialty pharmaceuticals and consumer healthcare products for dermatological conditions such as eczema, psoriasis, fungal complaints, and wound healing. The company has an established commercial presence in the UK with a history dating back to 1966. No recent clinical trial data found.

Therapeutic areas
DermatologyInfectious Diseases
Modalities
Small molecule
Industry
Biotech
02

Drug pipeline

4 assets

Dermacool Forte

4

3 more assets in the full pipeline.

Beyond the preview

Go deeper on Typharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Typharm.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call